PFF DISEASE EDUCATION WEBINAR SERIES. Welcome!

Similar documents
ASK A DOC. Clinical Trial Update May 28, Welcome!

Position Statement from the Irish Thoracic Society on the treatment of Idiopathic Pulmonary Fibrosis

nintedanib 100mg and 150mg capsules (Ofev ) SMC No. (1076/15) Boehringer Ingelheim

Staging of idiopathic pulmonary fibrosis: past, present and future

Idiopathic Pulmonary Fibrosis (IPF) Research

Forum of International Development Studies 21 (Mar. 2002)


CURRICULUM VITAE GREGORY JAMES FERREIRA M.D., FCCP

Southwark Clinical Commissioning Group Lambeth Clinical Commissioning Group

This article reports relevant progress in the. Interstitial lung disease CLINICAL YEAR IN REVIEW. Vincent Cottin*,#

National Institute for Health and Care Excellence. NICE Quality Standards Consultation Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis: the diagnosis and management of suspected idiopathic pulmonary fibrosis

National Learning Objectives for COPD Educators

Interstitial Lung Disease (Diffuse Parenchymal Lung Disease) Focusing on Idiopathic Pulmonary Fibrosis

STATE OF NEBRASKA STATUTES RELATING TO RESPIRATORY CARE PRACTICE ACT

National Emphysema Treatment Trial (NETT) Consent for Screening and Patient Registry

PLAN OF ACTION FOR. Physician Name Signature License Date

Transitional Care Management (TCM) Presented by Noridian Part B Medicare Provider Outreach and Education May 2016

Is it time for a new drug development paradigm?

Careers in Haematology

Providence Telemedicine Network

Performance Measures for. What? When? How?

Breaking News in Malattie dell Apparato Respiratorio

The Global Alliance against Chronic Respiratory Diseases

Evolution of a Closed Loop Medication Use Process

Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care

James F. Kravec, M.D., F.A.C.P

Improvement in Dyspnea Implementing Pulmonary Rehabilitation in the Home

PCOM Letterhead [Substitute same from participating institution and, of course, change Department, PI, and Co-Investigators]

Pulmonary Artery Hypertension

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Active Rehabilitation and Physical Therapy During Extracorporeal Membrane Oxygenation While Awaiting Lung Transplantation

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, Participating Faculty

CORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension

UW MEDICINE PATIENT EDUCATION. Your Care Team. Helpful information

Prevention of Acute COPD exacerbations

Scottish Medicines Consortium

The Importance of Meaningful Engagement in Research

Pharmacists: Access to Immunization Services. American Pharmacists Association Chief of Staff

Acute Care of COPD: Gaps in our knowledge. Robert A. Wise, M.D. May 20, 2010

Oncology Competency- Pain, Palliative Care, and Hospice Care

What we will discuss today

The 2014 Patient- Centered Primary Care Home (PCPCH) Recognition Criteria

Center of Excellence in Naturopathic Cardiovascular Medicine

Nurse Practitioners (NPs) and Physician Assistants (PAs): What s the Difference?

Secondary Uses of Data for Comparative Effectiveness Research

Pulmonary Rehabilitation. Use it or lose it??? By John R. Goodman BS RRT

Pulmonary Function Testing: Coding and Billing Issues

Hospice and Palliative Care: Help Throughout Life s Journey. John P. Langlois MD CarePartners Hospice and Palliative Care

Pulmonary Rehabilitation in Ontario: OHTAC Recommendation

Introducing Grace Bedford. Bringing long-term, acute care closer to you

INTERSTITIAL LUNG DISEASES Recent Advances That Change Practice

Adult Home Oxygen Therapy. Purpose To provide guidance on the requirements for and procedures relating to domiciliary oxygen therapy.

When choosing a destination, it is important to keep the following in mind:

Respiratory Therapy Careers. CTAE Resource Network Created by Caleb Allred and Dr. Frank Flanders 2010

IC 3 : Improving Continuous Cardiac Care Quality Improvement in Practice

Putting Patients at the Heart of what Value Means

Idiopathic Pulmonary Fibrosis

Oxygen and Oxygen Equipment Coverage and Documentation Checklist

Michael Zervas, Managing Partner

1. Phosphodiesterase Type 5 Enzyme Inhibitors: Sildenafil (Revatio), Tadalafil (Adcirca)

University of Kansas. Respiratory Care Education

Comprehensive Cardiac Care Program

October 8, :00 3:00pm EDT

NAVIGATING THE MEDICARE MAZE OF REHABILITATIVE SERVICES

SARCOIDOSIS. Signs and symptoms associated with specific organ involvement can include the following:

Wild Ducks Episode 7: Personalized Medicine Podcast IBM Watson to Join the War on Cancer

Pulmonary rehabilitation

Department of Surgery

Concept Series Paper on Disease Management

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain

Summary of the risk management plan (RMP) for Ofev (nintedanib)

CURRICULUM VITAE. Richard L. Trader Sr. MMsc RRT. PA-C. FCCM. Personal. Present Title

R. Kendall Smith, Jr., MD, SFHM. 601 NW 22 nd Court Wilton Manors, FL Phone: (954)

Guidelines for Use of Controlled Substances for the Treatment of Pain

Health Coaching: A New and Exciting Technique to Enhance Patient Self-Management and Improve Outcomes

Interconnectivity Respiratory Therapy and the Electronic Health Record

Big Time, Big Deal. Strategies for Creating a Successful Organization-wide EMR. Charles B Wang Community Health Center Laminasti (Ina) Elbaar

Northern Colorado Companies. The Power of Innovative Integration

Clinical Decision Support in Nursing

PIPC: Hepatitis Roundtable Summary and Recommendations on Dissemination and Implementation of Clinical Evidence

Index. Registry Report

Rehabilitation Where You Recover. Inpatient Rehabilitation Services at Albany Medical Center

#Aim2Innovate. Share session insights and questions socially. Genomics, Precision Medicine and the EHR 6/17/2015

Harness Care Cooperative Ltd Quality primary care services provided through local cooperation Company registration:

Personalized Career Pathway

Update in Pulmonary & Critical Care Medicine

COPD Patient 30-Day Hospital Readmission Reduction Program

CURRICULUM VITAE. Joseph Anthony Giaimo, D.O. FCCP, FACOI Singer Drive West Palm Beach, FL

HOUSE OF REPRESENTATIVES - FLOOR VERSION

Community Care Collaborative Integrated Behavioral Health Intervention for Chronic Disease Management Pass 3

Medication Reconciliation Process; Reducing Prescribing Errors

RESOURCE. Medical Case Management Benchmarks. ING Re Industry Survey

I. Current Cardiac Rehabilitation Requirements

Kevin B. Weiss, MD, MPH Senior Vice President for Institutional Accreditation

MOHA Midwest Occupational Health Associates

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Evaluation and Management Coding Advisor

A different kind of health insurance.

Transcription:

PFF DISEASE EDUCATION WEBINAR SERIES Welcome!

ASK A DOC Q+A WITH PFF MEDICAL TEAM Harold Collard, MD PFF Senior Medical Advisor, Research Advisory Forum Gregory Cosgrove, MD PFF Chief Medical Officer David Lederer, MD, MS PFF Senior Medical Advisor, Education & Awareness Kevin Flaherty, MD, MS Steering Committee Chairman, PFF CCN & Patient Registry Ganesh Raghu, MD PFF Medical Advisory Board Member

PFF DISEASE EDUCATION WEBINAR SERIES Ask-a-Doc: 2015 Updated IPF Treatment Guidelines

DISCLAIMER We are providing medication information only. The information presented in this webinar should not be interpreted as medical advice or recommendations. Please discuss your medical condition with your health care provider before making any changes to your medical regimen.

ATS/ERS/JRS/ALAT IPF TREATMENT GUIDELINES Raghu G et al. Am J Respir Crit Care Med. 2015:192(2):238-48.

What is a clinical practice guideline & why do they exist?

WHAT IS A CLINICAL PRACTICE GUIDELINE? A Clinical Practice Guidelines is a formal document developed by a group of experts that makes recommendations for patient care These recommendations are based on an exhaustive and systematic review of the available evidence Doctors, insurance companies, and policymakers often follow the recommendations in these guidelines Many consider guidelines to be the standard of care

WHAT IS THE PURPOSE OF THIS GUIDELINE? The purpose of the ATS/ERS/JRS/ALAT Clinical Practice Guideline for IPF is to provide guidance to clinicians about the role of different treatment options in IPF Meant to empower clinicians to make appropriate clinical decisions for individual patients with IPF.

Who developed this guideline?

FOUR PROFESSIONAL MEDICAL SOCIETIES DEVELOPED THE GUIDELINE

ATS/ERS/JRS/ALAT IPF TREATMENT GUIDELINES Raghu G et al. Am J Respir Crit Care Med. 2015:192(2):238-48.

ATS/ERS/JRS/ALAT IPF TREATMENT GUIDELINES

What do the new guidelines recommend?

STRONG VS. CONDITIONAL RECOMMENDATIONS Raghu G et al. Am J Respir Crit Care Med. 2015:192(2):238-48.

ATS/ERS/JRS/ALAT 2015 IPF GUIDELINES: RECOMMENDED FOR USE IN IPF STRONG Recommendation CONDITIONAL Recommendation Nintedanib Pirfenidone Antacid therapy Raghu G et al. Am J Respir Crit Care Med. 2015:192(2):238-48.

ATS/ERS/JRS/ALAT 2015 IPF GUIDELINES: RECOMMENDED AGAINST USE IN IPF STRONG Recommendation CONDITIONAL Recommendation Anticoagulation (warfarin) Prednisone + azathioprine + NAC Ambrisentan Macitentan and bosentan Sildenafil NAC alone CONFIDENTIAL Raghu G et al. Am J Respir Crit Care Med. 2015:192(2):238-48.

WHAT HAS NOT BEEN ADDRESSED BY THESE GUIDELINES? Treatment recommendations for types of PF other than IPF Role of lung transplantation Treatment of pulmonary hypertension in folks with IPF Recommendations for different diagnostic approaches Role of ILD centers in the management of patients with PF

Q&A I am taking one of the medications that has a recommendation against use designation in the new guidelines. What should I do? Is pirfenidone available for use as an inhaled medicine? Will this help eliminate some of the side effects? I take anticoagulant medication for a different medical problem. Should I stop taking this?

Q&A There were no strong recommendations FOR any treatment. Does this mean that I shouldn t accept any treatments for my IPF? I saw that the guidelines addressed Triple therapy. What about prednisone without azathioprine or NAC?

ATS/ERS/JRS/ALAT 2011 IPF GUIDELINES: RECOMMENDED FOR USE IN IPF THAT STILL STAND STRONG Recommendation CONDITIONAL Recommendation Oxygen Lung Transplantation Pulmonary rehabilitation Steroids (prednisone) during an acute exacerbation CONFIDENTIAL Raghu G et al. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824.

ATS/ERS/JRS/ALAT 2011 IPF GUIDELINES: RECOMMENDED AGAINST USE IN IPF THAT STILL STAND STRONG Recommendation CONDITIONAL Recommendation Prednisone alone for outpatient Mechanical ventilation during an acute exacerbation Raghu G et al. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824.

PFF SUMMIT 2015 PFF Summit 2015 provides an unparralleled opportunity to meet with physicians, researchers, patients, caregivers, industry representatives, and members of the international PF community all in one setting. Register today! www.pffsummit.org

Thank you.